Back to Search Start Over

A-133 Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma.

Authors :
Mitteldorf, C.
de Masson, A.
Beylot-Barry, M.
Wobster, M.
Zomas, A.
Stache, V.
Assaf, C.
Source :
European Journal of Cancer. 2024 Supplement 2, Vol. 211, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Details

Language :
English
ISSN :
09598049
Volume :
211
Database :
Academic Search Index
Journal :
European Journal of Cancer
Publication Type :
Academic Journal
Accession number :
180132534
Full Text :
https://doi.org/10.1016/j.ejca.2024.114491